Cargando…

Elevated Serum Levels of Interferon-Regulated Chemokines Are Biomarkers for Active Human Systemic Lupus Erythematosus

BACKGROUND: Systemic lupus erythematosus (SLE) is a serious systemic autoimmune disorder that affects multiple organ systems and is characterized by unpredictable flares of disease. Recent evidence indicates a role for type I interferon (IFN) in SLE pathogenesis; however, the downstream effects of I...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bauer, Jason W, Baechler, Emily C, Petri, Michelle, Batliwalla, Franak M, Crawford, Dianna, Ortmann, Ward A, Espe, Karl J, Li, Wentian, Patel, Dhavalkumar D, Gregersen, Peter K, Behrens, Timothy W
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2006
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1702557/ https://www.ncbi.nlm.nih.gov/pubmed/17177599 http://dx.doi.org/10.1371/journal.pmed.0030491

Ejemplares similares

A comparison of founder-only and all-pedigree-members genotype-expression association by regression analysis
por: Suh, Young Ju, et al.
Publicado: (2007)

Serum chemokine levels predict flares of disease activity in two independent systemic lupus erythematosus cohorts
por: Bilgic, H, et al.
Publicado: (2012)

Association of elevated transcript levels of interferon-inducible chemokines with disease activity and organ damage in systemic lupus erythematosus patients
por: Fu, Qiong, et al.
Publicado: (2008)

Longitudinal association of type 1 interferon-induced chemokines with disease activity in systemic lupus erythematosus
por: Connelly, K. L., et al.
Publicado: (2018)

Multiplex giant magnetoresistive biosensor microarrays identify interferon-associated autoantibodies in systemic lupus erythematosus
por: Lee, Jung-Rok, et al.
Publicado: (2016)

Specificity of the STAT4 Genetic Association for Severe Disease Manifestations of Systemic Lupus Erythematosus
por: Taylor, Kimberly E., et al.
Publicado: (2008)

Interferon Alpha in Systemic Lupus Erythematosus
por: Niewold, Timothy B., et al.
Publicado: (2010)

Cytokines and Chemokines in Neuropsychiatric Syndromes of Systemic Lupus Erythematosus
por: Okamoto, Hiroshi, et al.
Publicado: (2010)

Interferon-induced versus chemokine transcripts as lupus biomarkers
por: Crow, Mary K, et al.
Publicado: (2008)

Interferon targeted therapies in systemic lupus erythematosus
por: Misra, Durga Prasanna, et al.
Publicado: (2017)

Association of MIF, but not type I interferon-induced chemokines, with increased disease activity in Asian patients with systemic lupus erythematosus
por: Connelly, K. L., et al.
Publicado: (2016)

Risk Alleles for Systemic Lupus Erythematosus in a Large Case-Control Collection and Associations with Clinical Subphenotypes
por: Taylor, Kimberly E., et al.
Publicado: (2011)

Differential Genetic Associations for Systemic Lupus Erythematosus Based on Anti–dsDNA Autoantibody Production
por: Chung, Sharon A., et al.
Publicado: (2011)

The Role of Genetic Variation Near Interferon-Kappa in Systemic Lupus Erythematosus
por: Harley, Isaac T. W., et al.
Publicado: (2010)

Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood
por: Bennett, Lynda, et al.
Publicado: (2003)

Systemic lupus erythematosus and the type I interferon system
por: Rönnblom, Lars, et al.
Publicado: (2003)

Glycosphingolipid-associated β-1,4 galactosyltransferase is elevated in patients with systemic lupus erythematosus
por: Sadras, Vignesh, et al.
Publicado: (2020)

Interferon Regulatory Factor 5 in the Pathogenesis of Systemic Lupus Erythematosus
por: Cham, Candace M., et al.
Publicado: (2012)

Genetic linkage and transmission disequilibrium of marker haplotypes at chromosome 1q41 in human systemic lupus erythematosus
por: Graham, Robert R, et al.
Publicado: (2001)

Unmet medical needs in systemic lupus erythematosus
por: Lateef, Aisha, et al.
Publicado: (2012)

Interferon-lambda1 induces peripheral blood mononuclear cell-derived chemokines secretion in patients with systemic lupus erythematosus: its correlation with disease activity
por: Wu, Qian, et al.
Publicado: (2011)

Interferon alpha associated with systemic lupus erythematosus is not intrinsically acid labile
Publicado: (1989)

Chemokine CXCL1 as a potential marker of disease activity in systemic lupus erythematosus
por: Zeng, Yanli, et al.
Publicado: (2021)

Human CD11b(+) B1 cells are not monocytes: A reply to “Gene profiling of CD11b(+) and CD11b(−) B1 cell subsets reveals potential cell sorting artifacts”
por: Griffin, Daniel O., et al.
Publicado: (2012)

Blood autoantibody and cytokine profiles predict response to anti-tumor necrosis factor therapy in rheumatoid arthritis
por: Hueber, Wolfgang, et al.
Publicado: (2009)

Using the circulating proteome to assess type I interferon activity in systemic lupus erythematosus
por: Smith, Michael A., et al.
Publicado: (2020)

Evaluation of different ways to identify persistent positivity of lupus anticoagulant in systemic lupus erythematosus
por: Petri, Michelle A, et al.
Publicado: (2020)

Association study of genetic variants of pro-inflammatory chemokine and cytokine genes in systemic lupus erythematosus
por: Sánchez, Elena, et al.
Publicado: (2006)

Immunopathological Roles of Cytokines, Chemokines, Signaling Molecules, and Pattern-Recognition Receptors in Systemic Lupus Erythematosus
por: Yu, Shui-Lian, et al.
Publicado: (2012)

Circulating immune complexes contain citrullinated fibrinogen in rheumatoid arthritis
por: Zhao, Xiaoyan, et al.
Publicado: (2008)

Nucleic Acid Sensors and Type I Interferon Production in Systemic Lupus Erythematosus
por: Shrivastav, Meena, et al.
Publicado: (2013)

Type 1 interferon status in systemic lupus erythematosus: a longitudinal analysis
por: Northcott, Melissa, et al.
Publicado: (2022)

Chemokines and Chemokine Receptors in the Development of Lupus Nephritis
por: Liao, Xiaofeng, et al.
Publicado: (2016)

Cerebral Ischemia Enhances Polyamine Oxidation: Identification of Enzymatically Formed 3-Aminopropanal as an Endogenous Mediator of Neuronal and Glial Cell Death
por: Ivanova, Svetlana, et al.
Publicado: (1998)

Clinical and histopathological features of myositis in systemic lupus erythematosus
por: Tiniakou, Eleni, et al.
Publicado: (2022)

Elevated titers of anti-ribosomal-P antibodies in systemic lupus erythematosus
por: Zandman-Goddard, G, et al.
Publicado: (2005)

Serum Interleukin-34 Levels Are Elevated in Patients with Systemic Lupus Erythematosus
por: Wang, Hongxu, et al.
Publicado: (2016)

Elevated plasma midkine and pleiotrophin levels in patients with systemic lupus erythematosus
por: Wu, Guo-Cui, et al.
Publicado: (2016)

Development of a systemic lupus erythematosus cardiovascular risk equation
por: Petri, Michelle A, et al.
Publicado: (2019)

Lupus Erythematosus
por: Gardiner, Frederick
Publicado: (1923)

Cannot write session to /tmp/vufind_sessions/sess_8e7oitvesa2sqshv985v5p6g56